CPO
BIIB icon

Cerity Partners OCIO’s Biogen BIIB Stock Holding History

Cerity Partners OCIO’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-816
Closed -$258K – 334
2020
Q1 		$258K Sell
816
-159
-16% -$48.3K 0.01% 268
2019
Q4 		$330K Sell
975
-74
-7% -$20.5K 0.02% 260
2019
Q3 		$244K Sell
1,049
-62
-6% -$14.4K 0.01% 296
2019
Q2 		$260K Buy
1,111
+164
+17% +$37.9K 0.01% 285
2019
Q1 		$224K Buy
+947
New +$298K 0.01% 276

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cerity Partners OCIO's BIIB Position: Q2 2020 in Review

Cerity Partners OCIO sold out of Biogen (BIIB) in Q2 2020, closing a stake of 816 shares — an estimated $258K sold.

Cerity Partners OCIO first reported a position in BIIB in Q1 2019 and held it in 5 quarters. The position peaked at $330K in Q4 2019. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Cerity Partners OCIO reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Cerity Partners OCIO sold 816 Biogen shares in Q2 2020, an estimated $258K.
  • Cerity Partners OCIO first reported a position in Biogen in Q1 2019 and held it in 5 quarters.
  • Cerity Partners OCIO's Biogen position peaked at $330K in Q4 2019.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Cerity Partners OCIO's 13F filing for Q2 2020, filed 12 Aug 2020.